India launches 1st indigenous CRISPR-based gene therapy for Sickle Cell Disease
Setting a new milestone, the Indian government on November 20 launched an indigenous CRISPR-based gene therapy for Sickle Cell Disease, which particularly affects India`s tribal population.
The low-cost gene editing solution named "BIRSA 101", in honour of Bhagwan Birsa Munda, remembered as a great tribal freedom fighter, was launched by Union Minister of State (Independent Charge) for Science and Technology Dr Jitendra Singh.
The technology works like a “precise genetic surgery”, capable not only of curing Sickle Cell Disease but also transforming treatment pathways for several hereditary disorders, the minister explained.
Sickle Cell Disease is a chronic, single-gene disorder that causes a debilitating systemic syndrome characterised by chronic anaemia, acute painful episodes, organ ...










